Philips 2012 Annual Report Download - page 67

6 Sector performance 6.1.3 - 6.1.4
Annual Report 2012 67
Total sales by business 2012
as a %
Customer Services
25
Patient Care &
Clinical Informatics
22
Home Healthcare Solutions
15
Imaging
Systems
38
Philips is one of the world’s leading health care companies
(based on sales) along with General Electric and Siemens.
The United States, our largest market, represented 41%
of our Healthcare business’s global sales in 2012, followed
by Japan, China and Germany. Growth geographies
accounted for 24% of Healthcare sales. Philips Healthcare
employs approximately 37,500 employees worldwide.
Sales at Healthcare are generally higher in the second half
of the year largely due to the timing of new product
availability and customer spending patterns.
Regulatory requirements
Philips Healthcare is subject to extensive regulation. We
are committed to compliance with regulatory product
approval and quality system requirements in every market
we serve by addressing specific terms and conditions of
local and national regulatory authorities, including the US
FDA and comparable foreign agencies. Obtaining their
approval is costly and time-consuming, but a prerequisite
for market introduction.
With regard to sourcing, please refer to section 14.5,
Supplier indicators, of this Annual Report.
6.1.4 Progress against targets
The Annual Report 2011 set out a number of key targets
for Philips Healthcare in 2012 that are steps towards
achieving our Accelerate! mid-term 2013 goals. Our
progress is outlined below.
Implement Accelerate! transformation
The launch of Accelerating Healthcare in 2012 put us on
a fast track to eliminate organizational complexity as a
barrier to higher performance. We established Lean
operating principles and enhanced the alignment of our
product-creation and customer-facing teams to ensure
speed of execution while maintaining quality.
This included designing for cost by leveraging value
engineering.
We also continued to increase our presence and
industrial footprint in growth geographies and to expand
our value offering and locally relevant services.
Driving to co-leadership in Imaging Systems
Our Imaging 2.0 initiative continued to deliver share gains,
as well as awards for quality, performance and reliability,
with over 15 new products and features introduced in
2012. Our innovative integrated clinical solutions include
elastography; iterative image reconstruction technique
for virtually ”noise free” image quality; cardiovascular x-
ray system software that allows a significant reduction in
X-ray dose while preserving image quality; a software
application that converts analog MR images to digitized
MR images; and a multi-vendor workstation that
integrates image history across modality for easy
collaboration among physicians.
We announced new strategic alliances in 2012, including
a program with Elekta in Sweden to develop a potential
breakthrough in cancer care. We also entered into an
exclusive distribution agreement with Corindus Vascular
Robotics in the US for one of their state-of-the-art
robotic-assisted systems.
Achieving leadership with holistic
innovation in Patient Care & Clinical
Informatics
A number of important advancements in 2012 helped
strengthen our leadership position in clinical decision
support and address the specific needs of high-growth
geographies, such as Brazil, China and India. These
included FDA clearance for two groundbreaking clinical
decision support applications for our patient monitors,
and innovative solutions for interoperability,
defibrillation, clinical informatics, anesthesia care and
patient monitoring.
We also collaborated with customers on initiatives with
far-reaching implications. With Maxima Medical Center in
the Netherlands, we created a new concept in neonatal
intensive care called the Woman-Mother-Child Center,
where mothers and their newborn babies are kept
together for fully integrated treatment and nursing care.